# FDA 483 - Beigene (Suzhou) Co., Ltd. - June 16, 2023

Source: https://www.globalkeysolutions.net/records/483/beigene-suzhou-co-ltd/ea0358d7-576e-42a1-9d4e-45def2af5b8e

> FDA 483 for Beigene (Suzhou) Co., Ltd. on June 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Beigene (Suzhou) Co., Ltd.
- Inspection Date: 2023-06-16
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Officers

- [Jingjing Zhao, Ph.D.](https://www.globalkeysolutions.net/people/jingjing-zhao-phd/28f52c94-6f09-454c-b74f-62d6e2e9c85c)
- [investigator](https://www.globalkeysolutions.net/people/john-j-bernal/315c4532-4004-43f9-86e1-1bde15e9b2a6)
- [Lead  Biologist](https://www.globalkeysolutions.net/people/leiyun-boone/454ce531-ae82-4ae4-9b3d-8e4e8afed127)
- [Yiwei Li](https://www.globalkeysolutions.net/people/yiwei-li/e5ea2c24-8e1e-43be-be23-e276b8848cff)

Company: https://www.globalkeysolutions.net/companies/beigene-suzhou-co-ltd/10b8c1b1-d4b8-4272-a5bd-d1615d0df568

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1